The forecasted mortality rate for pancreas malignant neoplasms among females in Canada shows a gradual increase from 2.69 thousand deaths in 2024 to 2.83 thousand deaths by 2028. The year-on-year growth is relatively consistent, averaging approximately 1.25% annually over the five-year forecast period. In 2023, the mortality was slightly lower, indicating a steady upward trend in this unfortunate health statistic.
Key trends to monitor include advancements in early detection and treatment options for pancreatic cancer, which may impact these projections. Additionally, policy changes in healthcare and population demographics could further influence these mortality rates.
